| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Healthcare Disparities | 18 | 2022 | 153 | 4.850 |
Why?
|
| Medicare | 15 | 2022 | 185 | 3.960 |
Why?
|
| Papillomavirus Vaccines | 8 | 2021 | 36 | 3.340 |
Why?
|
| Hospitalization | 12 | 2022 | 417 | 2.860 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2019 | 154 | 2.650 |
Why?
|
| Continental Population Groups | 12 | 2020 | 221 | 2.600 |
Why?
|
| Health Care Reform | 11 | 2019 | 42 | 2.460 |
Why?
|
| Patient Readmission | 13 | 2022 | 105 | 2.390 |
Why?
|
| Vaccination | 7 | 2021 | 123 | 2.280 |
Why?
|
| Papillomavirus Infections | 7 | 2021 | 52 | 2.220 |
Why?
|
| Insurance Coverage | 11 | 2022 | 74 | 2.210 |
Why?
|
| United States | 45 | 2022 | 3604 | 2.190 |
Why?
|
| Hospital Mortality | 6 | 2019 | 186 | 2.120 |
Why?
|
| Ethnic Groups | 10 | 2020 | 440 | 2.060 |
Why?
|
| Emergency Service, Hospital | 6 | 2021 | 429 | 1.780 |
Why?
|
| Health Status Disparities | 6 | 2019 | 107 | 1.580 |
Why?
|
| Humans | 77 | 2022 | 29013 | 1.480 |
Why?
|
| Myocardial Infarction | 8 | 2019 | 412 | 1.420 |
Why?
|
| Aged | 37 | 2022 | 9462 | 1.400 |
Why?
|
| Female | 58 | 2020 | 18114 | 1.360 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 157 | 1.320 |
Why?
|
| Chronic Disease | 3 | 2018 | 369 | 1.260 |
Why?
|
| Medically Uninsured | 7 | 2019 | 31 | 1.210 |
Why?
|
| Condylomata Acuminata | 2 | 2017 | 7 | 1.160 |
Why?
|
| Male | 49 | 2020 | 17768 | 1.160 |
Why?
|
| Quality Indicators, Health Care | 6 | 2016 | 55 | 1.140 |
Why?
|
| Quality of Health Care | 5 | 2016 | 134 | 1.110 |
Why?
|
| Minority Groups | 3 | 2018 | 69 | 1.100 |
Why?
|
| Aged, 80 and over | 21 | 2020 | 3712 | 1.100 |
Why?
|
| Hispanic Americans | 9 | 2019 | 904 | 1.090 |
Why?
|
| Adolescent | 22 | 2021 | 3248 | 1.080 |
Why?
|
| Middle Aged | 38 | 2020 | 10805 | 1.050 |
Why?
|
| Retrospective Studies | 20 | 2020 | 3107 | 1.040 |
Why?
|
| Young Adult | 22 | 2020 | 2398 | 1.030 |
Why?
|
| Prospective Payment System | 2 | 2021 | 9 | 0.980 |
Why?
|
| African Americans | 9 | 2019 | 1373 | 0.970 |
Why?
|
| European Continental Ancestry Group | 11 | 2019 | 1131 | 0.930 |
Why?
|
| Adult | 28 | 2020 | 8391 | 0.920 |
Why?
|
| Insurance, Health | 7 | 2022 | 91 | 0.920 |
Why?
|
| Socioeconomic Factors | 10 | 2019 | 385 | 0.900 |
Why?
|
| Meningococcal Vaccines | 3 | 2021 | 8 | 0.900 |
Why?
|
| Anticoagulants | 2 | 2021 | 120 | 0.900 |
Why?
|
| United States Department of Veterans Affairs | 11 | 2018 | 49 | 0.890 |
Why?
|
| Heart Failure | 6 | 2021 | 567 | 0.890 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 142 | 0.850 |
Why?
|
| Ambulatory Care | 2 | 2019 | 96 | 0.810 |
Why?
|
| Health Services Accessibility | 9 | 2018 | 231 | 0.790 |
Why?
|
| Economics, Hospital | 2 | 2019 | 6 | 0.780 |
Why?
|
| Massachusetts | 13 | 2020 | 28 | 0.760 |
Why?
|
| Veterans | 2 | 2018 | 50 | 0.750 |
Why?
|
| Health Services | 2 | 2018 | 35 | 0.730 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 666 | 0.730 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 10 | 0.720 |
Why?
|
| Referral and Consultation | 2 | 2018 | 113 | 0.710 |
Why?
|
| Poverty | 3 | 2018 | 98 | 0.710 |
Why?
|
| Cohort Studies | 8 | 2021 | 1674 | 0.700 |
Why?
|
| Eligibility Determination | 2 | 2018 | 14 | 0.690 |
Why?
|
| Mammography | 1 | 2018 | 37 | 0.640 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 311 | 0.620 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 61 | 0.620 |
Why?
|
| Adolescent Health Services | 1 | 2017 | 11 | 0.610 |
Why?
|
| Hospitals | 5 | 2022 | 89 | 0.610 |
Why?
|
| Hypertension | 4 | 2020 | 899 | 0.610 |
Why?
|
| Ambulances | 1 | 2017 | 12 | 0.610 |
Why?
|
| Transportation of Patients | 1 | 2017 | 20 | 0.600 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 133 | 0.600 |
Why?
|
| Communication Barriers | 1 | 2017 | 22 | 0.600 |
Why?
|
| Language | 1 | 2017 | 44 | 0.590 |
Why?
|
| Documentation | 1 | 2016 | 32 | 0.580 |
Why?
|
| Information Dissemination | 1 | 2016 | 41 | 0.570 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 358 | 0.570 |
Why?
|
| Patient Admission | 1 | 2016 | 53 | 0.560 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2015 | 2 | 0.560 |
Why?
|
| Inpatients | 1 | 2016 | 64 | 0.550 |
Why?
|
| Radiography | 1 | 2017 | 353 | 0.550 |
Why?
|
| Health Policy | 1 | 2016 | 79 | 0.550 |
Why?
|
| Schools | 1 | 2016 | 64 | 0.540 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 17 | 0.520 |
Why?
|
| Immunization Programs | 1 | 2015 | 26 | 0.520 |
Why?
|
| Sexual Behavior | 1 | 2015 | 97 | 0.510 |
Why?
|
| Pneumonia | 5 | 2019 | 61 | 0.510 |
Why?
|
| Health Surveys | 3 | 2019 | 191 | 0.500 |
Why?
|
| Logistic Models | 5 | 2018 | 725 | 0.480 |
Why?
|
| Terminal Care | 4 | 2022 | 18 | 0.470 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2020 | 84 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2021 | 325 | 0.460 |
Why?
|
| Hospitals, Veterans | 4 | 2018 | 33 | 0.450 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2018 | 32 | 0.430 |
Why?
|
| Stroke | 2 | 2018 | 522 | 0.420 |
Why?
|
| Health Behavior | 2 | 2016 | 212 | 0.410 |
Why?
|
| Health Literacy | 3 | 2016 | 26 | 0.410 |
Why?
|
| Brain Ischemia | 1 | 2013 | 136 | 0.400 |
Why?
|
| Patient Discharge | 5 | 2019 | 168 | 0.360 |
Why?
|
| Educational Status | 3 | 2016 | 162 | 0.350 |
Why?
|
| Hospice Care | 1 | 2009 | 12 | 0.350 |
Why?
|
| United States Agency for Healthcare Research and Quality | 3 | 2013 | 5 | 0.340 |
Why?
|
| Medicaid | 3 | 2020 | 83 | 0.330 |
Why?
|
| Cross-Sectional Studies | 10 | 2020 | 1353 | 0.330 |
Why?
|
| Asian Americans | 2 | 2019 | 98 | 0.330 |
Why?
|
| Insurance Claim Review | 3 | 2020 | 27 | 0.330 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 708 | 0.330 |
Why?
|
| Health Services Research | 4 | 2018 | 78 | 0.330 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 25 | 0.320 |
Why?
|
| Income | 1 | 2008 | 51 | 0.320 |
Why?
|
| Health Care Costs | 1 | 2009 | 108 | 0.320 |
Why?
|
| Acute Disease | 2 | 2019 | 239 | 0.310 |
Why?
|
| Health Care Surveys | 2 | 2019 | 176 | 0.310 |
Why?
|
| Treatment Outcome | 7 | 2020 | 3099 | 0.310 |
Why?
|
| Diabetic Angiopathies | 2 | 2018 | 137 | 0.310 |
Why?
|
| African Continental Ancestry Group | 3 | 2016 | 350 | 0.300 |
Why?
|
| Asthma | 2 | 2022 | 397 | 0.300 |
Why?
|
| Child | 5 | 2021 | 2209 | 0.300 |
Why?
|
| Sentinel Surveillance | 2 | 2017 | 9 | 0.290 |
Why?
|
| Health Education | 3 | 2020 | 121 | 0.280 |
Why?
|
| Health Personnel | 2 | 2019 | 111 | 0.280 |
Why?
|
| Risk Factors | 7 | 2020 | 3509 | 0.270 |
Why?
|
| Patient Participation | 2 | 2016 | 62 | 0.260 |
Why?
|
| Databases, Factual | 2 | 2016 | 331 | 0.250 |
Why?
|
| Postural Balance | 1 | 2016 | 160 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 518 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 189 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2016 | 224 | 0.230 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 235 | 0.220 |
Why?
|
| Age Factors | 6 | 2020 | 1105 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 281 | 0.220 |
Why?
|
| Comorbidity | 4 | 2019 | 539 | 0.220 |
Why?
|
| Advance Care Planning | 1 | 2022 | 10 | 0.210 |
Why?
|
| Electronic Health Records | 3 | 2018 | 118 | 0.210 |
Why?
|
| Illinois | 1 | 2021 | 9 | 0.210 |
Why?
|
| Long-Term Care | 1 | 2021 | 21 | 0.210 |
Why?
|
| Parents | 2 | 2021 | 117 | 0.200 |
Why?
|
| Risk Adjustment | 3 | 2019 | 27 | 0.200 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 2021 | 2 | 0.200 |
Why?
|
| Women's Health Services | 1 | 2020 | 9 | 0.200 |
Why?
|
| Reproductive Health Services | 1 | 2020 | 5 | 0.200 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 29 | 0.200 |
Why?
|
| Epilepsy | 2 | 2011 | 59 | 0.190 |
Why?
|
| Reimbursement, Incentive | 1 | 2019 | 11 | 0.180 |
Why?
|
| Prevalence | 3 | 2018 | 892 | 0.180 |
Why?
|
| Research Design | 1 | 2021 | 285 | 0.180 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 70 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 48 | 0.180 |
Why?
|
| Meningococcal Infections | 2 | 2019 | 5 | 0.180 |
Why?
|
| Intention | 2 | 2019 | 27 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2019 | 175 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2017 | 2010 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2017 | 73 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 266 | 0.170 |
Why?
|
| Unemployment | 1 | 2018 | 4 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2019 | 272 | 0.170 |
Why?
|
| California | 1 | 2018 | 60 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2019 | 75 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2018 | 25 | 0.160 |
Why?
|
| Age Distribution | 1 | 2018 | 197 | 0.160 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 15 | 0.150 |
Why?
|
| Immunization Schedule | 1 | 2017 | 24 | 0.150 |
Why?
|
| Advisory Committees | 1 | 2017 | 32 | 0.150 |
Why?
|
| Acculturation | 1 | 2017 | 16 | 0.150 |
Why?
|
| Social Class | 1 | 2017 | 71 | 0.150 |
Why?
|
| Medical Informatics | 1 | 2016 | 18 | 0.150 |
Why?
|
| Data Mining | 1 | 2016 | 7 | 0.150 |
Why?
|
| Health Expenditures | 3 | 2019 | 61 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2017 | 110 | 0.140 |
Why?
|
| Organizational Policy | 1 | 2016 | 20 | 0.140 |
Why?
|
| Warfarin | 1 | 2016 | 30 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 109 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2017 | 119 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 863 | 0.140 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 8 | 0.140 |
Why?
|
| Software | 1 | 2016 | 109 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2015 | 16 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 150 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 23 | 0.140 |
Why?
|
| Hysterectomy | 1 | 2015 | 37 | 0.130 |
Why?
|
| Mass Screening | 1 | 2017 | 223 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 208 | 0.130 |
Why?
|
| Sex Factors | 4 | 2017 | 626 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2014 | 89 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2016 | 208 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2015 | 169 | 0.120 |
Why?
|
| Algorithms | 1 | 2016 | 461 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2013 | 37 | 0.110 |
Why?
|
| Residence Characteristics | 2 | 2011 | 177 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 77 | 0.110 |
Why?
|
| Costs and Cost Analysis | 3 | 2021 | 88 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2013 | 100 | 0.110 |
Why?
|
| Time Factors | 4 | 2020 | 1997 | 0.110 |
Why?
|
| Continuity of Patient Care | 2 | 2013 | 64 | 0.100 |
Why?
|
| New Jersey | 3 | 2016 | 10 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2010 | 185 | 0.100 |
Why?
|
| New York | 3 | 2016 | 18 | 0.100 |
Why?
|
| Terminally Ill | 1 | 2010 | 2 | 0.090 |
Why?
|
| Nursing Homes | 1 | 2010 | 41 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1062 | 0.090 |
Why?
|
| Hospital Administration | 1 | 2009 | 12 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2106 | 0.090 |
Why?
|
| Safety Management | 1 | 2009 | 31 | 0.090 |
Why?
|
| Survival Rate | 1 | 2010 | 795 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 462 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2008 | 178 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 159 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 1105 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 855 | 0.060 |
Why?
|
| Quality of Life | 2 | 2022 | 815 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 92 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1422 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 724 | 0.050 |
Why?
|
| Hospital-Physician Relations | 1 | 2021 | 5 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2014 | 160 | 0.050 |
Why?
|
| Contraception | 1 | 2020 | 12 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2020 | 47 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 52 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2022 | 259 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 24 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 71 | 0.040 |
Why?
|
| Occult Blood | 1 | 2017 | 9 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2019 | 144 | 0.040 |
Why?
|
| New York City | 1 | 2017 | 13 | 0.040 |
Why?
|
| Boston | 1 | 2017 | 16 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2017 | 41 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 368 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2016 | 7 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 23 | 0.040 |
Why?
|
| Markov Chains | 1 | 2016 | 25 | 0.040 |
Why?
|
| Alcoholism | 1 | 2017 | 95 | 0.040 |
Why?
|
| Executive Function | 1 | 2016 | 54 | 0.040 |
Why?
|
| Endometrial Hyperplasia | 1 | 2015 | 14 | 0.030 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2015 | 7 | 0.030 |
Why?
|
| Software Design | 1 | 2015 | 5 | 0.030 |
Why?
|
| Laparotomy | 1 | 2015 | 32 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 129 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2016 | 90 | 0.030 |
Why?
|
| Urban Population | 1 | 2016 | 79 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 77 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 378 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 289 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 87 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 291 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 373 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 6 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 10 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 862 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 7 | 0.030 |
Why?
|
| Proline | 1 | 2013 | 10 | 0.030 |
Why?
|
| Interferons | 1 | 2013 | 17 | 0.030 |
Why?
|
| Ribavirin | 1 | 2013 | 28 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2013 | 16 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2013 | 51 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 446 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 60 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 74 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 273 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2011 | 9 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 440 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2011 | 140 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2011 | 63 | 0.030 |
Why?
|
| Genotype | 1 | 2013 | 735 | 0.030 |
Why?
|
| Models, Nursing | 1 | 2011 | 1 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2011 | 10 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 237 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2010 | 11 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 784 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2009 | 26 | 0.020 |
Why?
|